25 agosto 2015
New research could potentially yield a new platform for cancer vaccines. Leveraging a biologically inspired sponge-like gel called ‘cryogel’ as an injectable biomaterial, the vaccine delivers patient-specific tumor cells together with immune-stimulating biomolecules to enhance the body’s attack against cancer.
http://www.sciencedaily.com/releases/2015/08/150825125809.htm
